• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Vascular health late after Kawasaki disease: implications for accelerated atherosclerosis.川崎病后晚期血管健康:对加速动脉粥样硬化的影响
Korean J Pediatr. 2014 Nov;57(11):472-8. doi: 10.3345/kjp.2014.57.11.472. Epub 2014 Nov 30.
2
An Update on Cardiovascular Risk Factors After Kawasaki Disease.川崎病后心血管危险因素的最新进展
Front Cardiovasc Med. 2021 Apr 16;8:671198. doi: 10.3389/fcvm.2021.671198. eCollection 2021.
3
Arterial hemodynamics in patients after Kawasaki disease.川崎病患者的动脉血流动力学
Circulation. 2005 Apr 26;111(16):2119-25. doi: 10.1161/01.CIR.0000162483.51132.25.
4
Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides.系统性血管炎导致的心血管疾病与动脉粥样硬化加速有关。
Best Pract Res Clin Rheumatol. 2013 Feb;27(1):33-44. doi: 10.1016/j.berh.2012.12.004.
5
Mid-term Risk for Subclinical Atherosclerosis and Chronic Myocarditis in Children with Kawasaki Disease and Transient Coronary Abnormalities.川崎病和短暂性冠状动脉异常患儿亚临床动脉粥样硬化和慢性心肌炎的中期风险
Pediatr Cardiol. 2017 Aug;38(6):1123-1132. doi: 10.1007/s00246-017-1626-5. Epub 2017 May 17.
6
Kawasaki disease: late cardiovascular sequelae.川崎病:晚期心血管后遗症。
Curr Opin Cardiol. 2012 Nov;27(6):572-7. doi: 10.1097/HCO.0b013e3283588f06.
7
Long-term prognosis of patients with Kawasaki disease: at risk for future atherosclerosis?川崎病患者的长期预后:未来有动脉粥样硬化风险?
J Nippon Med Sch. 2009 Jun;76(3):124-33. doi: 10.1272/jnms.76.124.
8
Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.川崎病晚期高敏C反应蛋白和血清淀粉样蛋白A水平升高:川崎病炎症与晚期冠状动脉后遗症之间的关联
Circulation. 2005 Jan 4;111(1):38-43. doi: 10.1161/01.CIR.0000151311.38708.29. Epub 2004 Dec 20.
9
Understanding the importance of cerebrovascular involvement in Kawasaki disease.了解川崎病中脑血管受累的重要性。
Korean J Pediatr. 2019 Sep;62(9):334-339. doi: 10.3345/kjp.2019.00143. Epub 2019 May 16.
10
Recent updates on echocardiography and ultrasound for Kawasaki disease: beyond the coronary artery.川崎病超声心动图和超声检查的最新进展:冠状动脉之外的情况
Cardiovasc Diagn Ther. 2018 Feb;8(1):80-89. doi: 10.21037/cdt.2017.06.09.

引用本文的文献

1
Interleukin-1 Signaling on Vascular Smooth Muscle Cells Accelerates Atherosclerosis in a Murine Model of Kawasaki Disease.白细胞介素-1在血管平滑肌细胞上的信号传导在川崎病小鼠模型中加速动脉粥样硬化。
J Am Heart Assoc. 2025 Jun 3;14(11):e040687. doi: 10.1161/JAHA.124.040687. Epub 2025 May 26.
2
Markers of Endothelial Dysfunction in Kawasaki Disease: An Update.川崎病内皮功能障碍标志物:最新研究进展。
Clin Rev Allergy Immunol. 2024 Feb;66(1):99-111. doi: 10.1007/s12016-024-08985-5. Epub 2024 Mar 11.
3
Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis.川崎病相关血管炎中内皮功能障碍的分子机制
Front Cardiovasc Med. 2022 Aug 8;9:981010. doi: 10.3389/fcvm.2022.981010. eCollection 2022.
4
Physicians' Self-reported Exercise Testing and Physical Activity Recommendations in Kawasaki Patients.川崎病患者中医生自我报告的运动测试及体力活动建议
Pediatr Cardiol. 2023 Mar;44(3):631-639. doi: 10.1007/s00246-022-02984-z. Epub 2022 Aug 11.
5
eQTL Highlights the Potential Role of Negative Control of Innate Immunity in Kawasaki Disease.表达数量性状基因座揭示了先天免疫负调控在川崎病中的潜在作用。
Int J Gen Med. 2022 Jan 22;15:837-848. doi: 10.2147/IJGM.S343225. eCollection 2022.
6
The role of peroxisome proliferator-activated receptor gamma and adiponectin in children with Kawasaki disease.过氧化物酶体增殖物激活受体γ和脂联素在川崎病患儿中的作用。
J Int Med Res. 2021 Mar;49(3):300060521994925. doi: 10.1177/0300060521994925.
7
Arterial stiffness late after Kawasaki disease in children: Assessment by performing brachial-ankle pulse wave velocity.川崎病患儿远期动脉僵硬度:肱踝脉搏波速度评估。
J Chin Med Assoc. 2020 Oct;83(10):931-935. doi: 10.1097/JCMA.0000000000000406.
8
Oxidised Low-Density Lipoprotein and Its Receptor-Mediated Endothelial Dysfunction Are Associated with Coronary Artery Lesions in Kawasaki Disease.氧化型低密度脂蛋白及其受体介导的内皮功能障碍与川崎病冠状动脉病变相关。
J Cardiovasc Transl Res. 2020 Apr;13(2):204-214. doi: 10.1007/s12265-019-09908-y. Epub 2019 Aug 19.
9
Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks.川崎病:意大利儿科学会指南,第二部分——抵抗形式和心血管并发症的治疗、随访、生活方式和心血管风险预防。
Ital J Pediatr. 2018 Aug 30;44(1):103. doi: 10.1186/s13052-018-0529-2.
10
Quercetin Inhibits Inflammasome Activation by Interfering with ASC Oligomerization and Prevents Interleukin-1 Mediated Mouse Vasculitis.槲皮素通过干扰 ASC 寡聚化抑制炎症小体激活,并预防白细胞介素-1 介导的小鼠血管炎。
Sci Rep. 2017 Feb 2;7:41539. doi: 10.1038/srep41539.

本文引用的文献

1
Left ventricular mechanics in adolescents and young adults with a history of kawasaki disease: analysis by three-dimensional speckle tracking echocardiography.有川崎病病史的青少年和青年的左心室力学:三维斑点追踪超声心动图分析
Echocardiography. 2014 Apr;31(4):483-91. doi: 10.1111/echo.12394. Epub 2013 Nov 9.
2
The biophysical properties of the aorta are altered following Kawasaki disease.大动脉的生物物理特性在川崎病后发生改变。
J Am Soc Echocardiogr. 2013 Dec;26(12):1388-96. doi: 10.1016/j.echo.2013.08.022. Epub 2013 Oct 4.
3
Mortality among Japanese with a history of Kawasaki disease: results at the end of 2009.日本川崎病病史患者的死亡率:2009 年底的结果。
J Epidemiol. 2013;23(6):429-34. doi: 10.2188/jea.je20130048. Epub 2013 Sep 14.
4
Vascular health in Kawasaki disease.川崎病的血管健康。
J Am Coll Cardiol. 2013 Sep 17;62(12):1114-1121. doi: 10.1016/j.jacc.2013.04.090. Epub 2013 Jul 10.
5
Echo-Doppler assessment of arterial stiffness in pediatric patients with Kawasaki disease.超声多普勒评估川崎病患儿的动脉僵硬度。
J Am Soc Echocardiogr. 2013 Sep;26(9):1084-9. doi: 10.1016/j.echo.2013.05.015. Epub 2013 Jun 22.
6
Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study.三种相关的血管病变过程可作为川崎病的特征:光镜和透射电镜研究。
PLoS One. 2012;7(6):e38998. doi: 10.1371/journal.pone.0038998. Epub 2012 Jun 18.
7
Marked acceleration of atherosclerosis after Lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease.酪酸梭菌诱导川崎病小鼠模型冠状动脉炎后动脉粥样硬化明显加速。
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):e60-71. doi: 10.1161/ATVBAHA.112.249417. Epub 2012 May 24.
8
Characteristics of earlier atherosclerotic involvement in adolescent patients with Kawasaki disease and coronary artery lesions: significance of gray scale median on B-mode ultrasound.青少年川崎病合并冠状动脉病变患者早期粥样硬化特点:B 型灰阶超声中灰度中位数的意义。
Atherosclerosis. 2012 May;222(1):106-9. doi: 10.1016/j.atherosclerosis.2012.01.049. Epub 2012 Feb 7.
9
Persistent coronary arterial inflammation in a patient long after the onset of Kawasaki disease.川崎病发病很久后患者持续存在的冠状动脉炎症。
Int J Cardiol. 2012 Jan 26;154(2):193-4. doi: 10.1016/j.ijcard.2011.10.078. Epub 2011 Nov 9.
10
Acute coronary syndrome in adult patients with coronary artery lesions caused by Kawasaki disease: review of case reports.川崎病所致冠状动脉病变成年患者的急性冠状动脉综合征:病例报告综述
Cardiol Young. 2011 Feb;21(1):74-82. doi: 10.1017/S1047951110001502. Epub 2010 Nov 12.

川崎病后晚期血管健康:对加速动脉粥样硬化的影响

Vascular health late after Kawasaki disease: implications for accelerated atherosclerosis.

作者信息

Cheung Yiu-Fai

机构信息

Division of Paediatric Cardiology, Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.

出版信息

Korean J Pediatr. 2014 Nov;57(11):472-8. doi: 10.3345/kjp.2014.57.11.472. Epub 2014 Nov 30.

DOI:10.3345/kjp.2014.57.11.472
PMID:25550701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4279007/
Abstract

Kawasaki disease (KD), an acute vasculitis that primarily affects young children, is the most common acquired paediatric cardiovascular disease in developed countries. While sequelae of arterial inflammation in the acute phase of KD are well documented, its late effects on vascular health are increasingly unveiled. Late vascular dysfunction is characterized by structural alterations and functional impairment in term of arterial stiffening and endothelial dysfunction and shown to involve both coronary and systemic arteries. Further evidence suggests that continuous low grade inflammation and ongoing active remodeling of coronary arterial lesions occur late after acute illness and may play a role in structural and functional alterations of the arteries. Potential importance of genetic modulation on vascular health late after KD is implicated by associations between mannose binding lectin and inflammatory gene polymorphisms with severity of peripheral arterial stiffening and carotid intima-media thickening. The changes in cholesterol and lipoproteins levels late after KD further appear similar to those proposed to be atherogenic. While data on adverse vascular health are less controversial in patients with persistent or regressed coronary arterial aneurysms, data appear conflicting in individuals with no coronary arterial involvements or only transient coronary ectasia. Notwithstanding, concerns have been raised with regard to predisposition of KD in childhood to accelerated atherosclerosis in adulthood. Until further evidence-based data are available, however, it remains important to assess and monitor cardiovascular risk factors and to promote cardiovascular health in children with a history of KD in the long term.

摘要

川崎病(KD)是一种主要影响幼儿的急性血管炎,是发达国家最常见的后天性儿童心血管疾病。虽然KD急性期动脉炎症的后遗症已有充分记录,但其对血管健康的后期影响也日益显现。晚期血管功能障碍的特征是动脉僵硬和内皮功能障碍方面的结构改变和功能损害,且已证明累及冠状动脉和全身动脉。进一步的证据表明,急性疾病后晚期会发生持续的低度炎症和冠状动脉病变的持续活跃重塑,这可能在动脉的结构和功能改变中起作用。甘露糖结合凝集素和炎症基因多态性与外周动脉僵硬严重程度和颈动脉内膜中层增厚之间的关联,暗示了基因调节对KD后晚期血管健康的潜在重要性。KD后晚期胆固醇和脂蛋白水平的变化进一步显示与那些被认为具有致动脉粥样硬化作用的变化相似。虽然在患有持续性或消退性冠状动脉瘤的患者中,关于不良血管健康的数据争议较小,但在没有冠状动脉受累或仅有短暂冠状动脉扩张的个体中,数据似乎相互矛盾。尽管如此,人们已经对儿童期KD易患成年期加速动脉粥样硬化提出了担忧。然而,在有更多循证数据之前,长期评估和监测有KD病史儿童的心血管危险因素并促进其心血管健康仍然很重要。